Mifepristone REMS Modifications Likely Violated Administrative Procedure Act, Appeals Court Says
Executive Summary
If ruling against US FDA by 5th Circuit is enacted, access to the medication abortion would revert to pre-2016 restrictions, meaning the product would be indicated for a maximum gestational age of forty-nine days and would need to be administered in person.